Advertisement

Topics

Genosco Company Profile

10:57 EDT 22nd July 2018 | BioPortfolio

Located in Cambridge, MA, Genosco is a clinical-stage biotechnology company led by CEO, Dr. Jong Sung (John) Koh, focusing on developing and commercializing novel immunology and oncology treatments to improve the lives of patients. Genosco’s core competence comes from its expertise in generating selective kinase inhibitors that include candidates that target EGFRm+ (NSCLC), SYK (Autoimmune diseases) and FLT3/AXL (AML) and other conditions. The company is enrolling patients in a Phase 1 study of SKI-G-801 for AML and expects to initiate a Phase 2 study of SKI-O-703 in ITP and RA in 2018. In 2015, Genosco partnered globally with Yuhan Corporation for development and commercialization of lazertinib (YH25448, GNS-1480), a 3rd-generation EGFR-TKI, for treatment of NSCLC currently in Phase 2 clinical trials. Genosco was founded in 2008 as a subsidiary company of Oscotec, Inc, (KOSDAQ: 039200), South Korea. For more information, please visit www.genosco.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

Genosco reports Phase I/II data for EGFR TKI in NSCLC

Genosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018

Genosco, a clinical-stage biotechnology company focused in immunology and oncology, today announced that the abstract from a Phase 1/2 study evaluating YH25448 (GNS-1480) in patie...

ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC

Genosco, a clinical-stage biotechnology company focused in immunology and oncology, announced data from a Phase 1/2 study evaluating lazertinib (YH25448, GNS-1480) in patients wit...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Genosco

Located in Cambridge, MA, Genosco is a clinical-stage biotechnology company led by CEO, Dr. Jong Sung (John) Koh, focusing on developing and commercializing novel immunology an...

More Information about "Genosco" on BioPortfolio

We have published hundreds of Genosco news stories on BioPortfolio along with dozens of Genosco Clinical Trials and PubMed Articles about Genosco for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genosco Companies in our database. You can also find out about relevant Genosco Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record